|Bid||3.00 x 700|
|Ask||0.00 x 0|
|Day's range||3.38 - 3.57|
|52-week range||2.43 - 9.54|
|PE ratio (TTM)||N/A|
|Earnings date||28 Jul 2017 - 31 Jul 2017|
|Forward dividend & yield||N/A (N/A)|
|1y target est||5.11|
The Buena, New Jersey-based company said it had a loss of 11 cents per share. Losses, adjusted for non-recurring costs and stock option expense, came to 6 cents per share. The specialty generic pharmaceutical ...
Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced today that Damian Finio has been appointed Chief Financial Officer of Teligent, Inc., effective February 5, 2018. Mr. Finio is currently the CFO of Virtus Pharmaceuticals, Inc., and will succeed Jenniffer Collins, who is leaving Teligent to pursue personal and professional opportunities and has agreed to stay on through May in a transitional capacity.
On a per-share basis, the Buena, New Jersey-based company said it had a loss of 12 cents. Losses, adjusted for non-recurring costs and amortization costs, came to 8 cents per share. The results did not ...